AAIC 2025 Abstract
Passive amylin immunotherapy improves brain function and reduces brain β‐amyloid pathology in APP/PS1 mice
Experiments in animalsInterventions
Abstract
Background: Amylin, a systemic hormone that is co‐secreted with insulin by pancreatic β‐cell, co‐aggregates with brain parenchymal and vascular β‐amyloid in persons with Alzheimer's disease (AD).
